Frontiers in Microbiology · 2019 · 40 citations · 30 references
Life SciencesInfectious DiseasesMicrobiologyBacteriologyMedical MicrobiologyMicrobial PathogenesisBacterial BiofilmsBiofilm FormationBiofilm Formation In InfectionImplant-associated InfectionMicrobial BiofilmsMicrobiological AnalysisBiofilm InhibitionBiofilm-associated Antimicrobial ResistanceBiofilm-associated InfectionsImplant-associated BiofilmsMicrobiology Of Implant-associated InfectionMinimum Biofilm Eradication ConcentrationPersister Cell FormationStaphylococcus Aureus Detection
biofilm was tolerant to all the antibiotics tested [minimum biofilm bactericidal concentration (MBBC) > 256 μg/ml], except to daptomycin [MBBC and minimum biofilm eradicating concentration (MBEC) = 32 μg/ml] and rifampin (MBBC and MBEC = 128 μg/ml). After the treatment of MRSA biofilm with 1024 μg/ml vancomycin, ∼5% cells survived, although metabolically inactive (persisters). Interestingly, IMC revealed that persister bacteria reverted to a normal-growing phenotype when inoculated into fresh medium without antibiotics. A staggered treatment of MRSA biofilm with vancomycin to kill all the metabolically active cells and daptomycin to kill persister cells eradicated the whole bacterial population. These results support the use in the clinical practice of a therapeutic regimen based on the use of two antibiotics to kill persister cells and eradicate MRSA biofilms. IMC represents a suitable technique to characterize in real-time the reversion from persister to metabolically-active cells.
30
Catherine Liu, Arnold S. Bayer, Sara E. Cosgrove et al. · Clinical Infectious Diseases · 2011 · 4.2K citations · Full text
Whole genome sequencing of meticillin-resistant Staphylococcus aureus
Makoto Kuroda, Toshiko Ohta, Ikuo Uchiyama et al. · The Lancet · 2001 · 2K citations · Full text
Catherine Liu, Arnold S. Bayer, Sara E. Cosgrove et al. · Clinical Infectious Diseases · 2011 · 1.6K citations · Full text